Example: Heart Attack

Search clinical trials for: Naltrexone

Total 434 results

NCT04250792

Completed

Efficacy of Low Dose Naltrexone in Psoriasis

Conditions: Psoriasis
NCT02911597

Completed

Double-Blind Trial of Ketamine Therapy Plus or Minus Naltrexone in Treatment Resistant Depression (TRD)

Conditions: Depression
NCT03647774

Recruiting

Long Acting Naltrexone for Opioid Addiction: Focus on Sustained Abstinence and Recovery

Conditions: Opioid-use Disorder
NCT01560013

Unknown status

The Effects of Treatment With Naltrexone in Alcohol and Cannabis-dependent Patients

Conditions: Alcohol-dependence
NCT02978417

Completed

Feasibility Study of Extended-release Naltrexone (Vivitrol) in Drug Court Settings

Conditions: Opioid-Related Disorders
NCT03810495

Active, not recruiting

OLANI PK/Safety Study in Healthy Volunteers

Conditions: Opioid Use Disorder
NCT02088177

Completed

Study of Long-Acting Injectable Naltrexone to Treat Cannabis Dependence

Conditions: Cannabis Dependence
NCT01625611

Recruiting

Kappa-PET Imaging and Naltrexone in Alcohol Drinking Behaviors

Conditions: Alcohol Drinking
NCT04547985

Recruiting

Naltrexone Treatment for Prolonged Grief Disorder (PGD)

Conditions: Prolonged Grief Disorder
NCT04678895

Recruiting

Low-Dose Naltrexone for the Treatment of Painful Diabetic Neuropathy

Conditions: Painful Diabetic Neuropathy
NCT02726035

Withdrawn

Evaluation of Naltrexone as a Treatment for Self-injurious Behavior

Conditions: Self-injurious Behavior; Self Mutilation
NCT02324725

Active, not recruiting

Biomarkers of Injectable Extended Release Naltrexone Treatment

Conditions: Heroin Dependence; Opioid Dependence
NCT02107014

Completed

Low Dose Naltrexone (LDN) Immune Monitoring

Conditions: Fibromyalgia
NCT01471145

Completed

Depot Naltrexone Mechanism of Action in Heroin Dependent Patients Using fMRI and SPECT

Conditions: Opioid-Related Disorders; Heroin Dependence
NCT00577408

Completed

Behavioral Naltrexone Therapy for Promoting Adherence to Oral Naltrexone vs Extended Release Injectable Depot Naltrexone

Conditions: Opiate Dependence; Heroin Dependence
NCT02965768

Suspended

Immune Effects of Low-dose Naltrexone in ME/CFS

Conditions: Fatigue Syndrome, Chronic
NCT02806440

Unknown status

Low Dose Naltrexone for Treatment of Pain in Patients With Fibromyalgia - Effect Via a Central Mechanism?

Conditions: Fibromyalgia
NCT03658330

Completed

Naltrexone Plus Ketamine for the Rapid Treatment of Major Depressive Disorder and Alcohol Use Disorder

Conditions: Major Depressive Disorder; Alcohol Use Disorder
NCT01893827

Completed

Extended-Release vs. Oral Naltrexone Alcohol Treatment in Primary Care

Conditions: Alcohol Dependence
NCT01246401

Completed

Naltrexone for Opioid Dependent Released Human Immunodeficiency Virus Positive (HIV+) Criminal Justice Populations

Conditions: HIV; AIDS; Opioid Dependence; Drug Dependence
NCT01810185

Withdrawn

Low Dose Naltrexone in Symptomatic Inflammatory Bowel Disease

Conditions: Inflammatory Bowel Disease; Crohn's Disease; Ulcerative Colitis
NCT02617628

Completed

Outcomes of Opioid Addicted Prisoners With Extended-Release Injectable Naltrexone

Conditions: Opiate Dependence
NCT02026011

Completed

Naltrexone for Individuals of East Asian Descent

Conditions: Alcohol Use Disorder
NCT01873729

Completed

An Open-Label Study of Naltrexone in Adults With Attention Deficit Hyperactivity Disorder.

Conditions: Attention Deficit Hyperactivity Disorder
NCT01882361

Completed

Opioid Relapse & HIV Risk: 48 Versus 24 Weeks of Injectable Extended Release Naltrexone

Conditions: Opiate Dependence; Human Immunodeficiency Virus